Report Detail
Global Sunitinib Generics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4753033 |
- 05 October, 2026 |
- Global |
- 100 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Sunitinib Generics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Sunitinib generics are alternative versions of the branded drug Sunitinib,used primarily for treating cancers such as renal cell carcinoma,gastrointestinal stromal tumors(GISTs),and pancreatic neuroendocrine tumors.These generic versions contain the same active ingredient—sunitinib malate,and have the same therapeutic effects as the brand-name product.Sunitinib generics are typically available in capsule form and are administered according to a treatment schedule tailored to the patient's condition.
This report is a detailed and comprehensive analysis for global Sunitinib Generics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sunitinib Generics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sunitinib Generics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sunitinib Generics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sunitinib Generics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sunitinib Generics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sunitinib Generics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Zydus, Aprazer Healthcare, Taj Pharma, Qilu Pharmaceutical, CSPC Pharmaceutical, Hansoh Pharma, Chia Tai Tianqing, Hunan Kelun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sunitinib Generics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
12.5mg per Unit
20mg per Unit
37.5mg per Unit
50mg per Unit
Market segment by Application
Renal cell Carcinoma
Gastrointestinal Stromal Tumors
Pancreatic Neuroendocrine Tumors
Other
Major players covered
Teva
Zydus
Aprazer Healthcare
Taj Pharma
Qilu Pharmaceutical
CSPC Pharmaceutical
Hansoh Pharma
Chia Tai Tianqing
Hunan Kelun Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sunitinib Generics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sunitinib Generics, with price, sales quantity, revenue, and global market share of Sunitinib Generics from 2021 to 2026.
Chapter 3, the Sunitinib Generics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sunitinib Generics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sunitinib Generics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sunitinib Generics.
Chapter 14 and 15, to describe Sunitinib Generics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Sunitinib Generics Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 12.5mg per Unit
- 1.3.3 20mg per Unit
- 1.3.4 37.5mg per Unit
- 1.3.5 50mg per Unit
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Sunitinib Generics Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Renal cell Carcinoma
- 1.4.3 Gastrointestinal Stromal Tumors
- 1.4.4 Pancreatic Neuroendocrine Tumors
- 1.4.5 Other
- 1.5 Global Sunitinib Generics Market Size & Forecast
- 1.5.1 Global Sunitinib Generics Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Sunitinib Generics Sales Quantity (2021-2032)
- 1.5.3 Global Sunitinib Generics Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Teva
- 2.1.1 Teva Details
- 2.1.2 Teva Major Business
- 2.1.3 Teva Sunitinib Generics Product and Services
- 2.1.4 Teva Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Teva Recent Developments/Updates
- 2.2 Zydus
- 2.2.1 Zydus Details
- 2.2.2 Zydus Major Business
- 2.2.3 Zydus Sunitinib Generics Product and Services
- 2.2.4 Zydus Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Zydus Recent Developments/Updates
- 2.3 Aprazer Healthcare
- 2.3.1 Aprazer Healthcare Details
- 2.3.2 Aprazer Healthcare Major Business
- 2.3.3 Aprazer Healthcare Sunitinib Generics Product and Services
- 2.3.4 Aprazer Healthcare Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Aprazer Healthcare Recent Developments/Updates
- 2.4 Taj Pharma
- 2.4.1 Taj Pharma Details
- 2.4.2 Taj Pharma Major Business
- 2.4.3 Taj Pharma Sunitinib Generics Product and Services
- 2.4.4 Taj Pharma Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Taj Pharma Recent Developments/Updates
- 2.5 Qilu Pharmaceutical
- 2.5.1 Qilu Pharmaceutical Details
- 2.5.2 Qilu Pharmaceutical Major Business
- 2.5.3 Qilu Pharmaceutical Sunitinib Generics Product and Services
- 2.5.4 Qilu Pharmaceutical Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Qilu Pharmaceutical Recent Developments/Updates
- 2.6 CSPC Pharmaceutical
- 2.6.1 CSPC Pharmaceutical Details
- 2.6.2 CSPC Pharmaceutical Major Business
- 2.6.3 CSPC Pharmaceutical Sunitinib Generics Product and Services
- 2.6.4 CSPC Pharmaceutical Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 CSPC Pharmaceutical Recent Developments/Updates
- 2.7 Hansoh Pharma
- 2.7.1 Hansoh Pharma Details
- 2.7.2 Hansoh Pharma Major Business
- 2.7.3 Hansoh Pharma Sunitinib Generics Product and Services
- 2.7.4 Hansoh Pharma Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Hansoh Pharma Recent Developments/Updates
- 2.8 Chia Tai Tianqing
- 2.8.1 Chia Tai Tianqing Details
- 2.8.2 Chia Tai Tianqing Major Business
- 2.8.3 Chia Tai Tianqing Sunitinib Generics Product and Services
- 2.8.4 Chia Tai Tianqing Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Chia Tai Tianqing Recent Developments/Updates
- 2.9 Hunan Kelun Pharmaceutical
- 2.9.1 Hunan Kelun Pharmaceutical Details
- 2.9.2 Hunan Kelun Pharmaceutical Major Business
- 2.9.3 Hunan Kelun Pharmaceutical Sunitinib Generics Product and Services
- 2.9.4 Hunan Kelun Pharmaceutical Sunitinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Hunan Kelun Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Sunitinib Generics by Manufacturer
- 3.1 Global Sunitinib Generics Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Sunitinib Generics Revenue by Manufacturer (2021-2026)
- 3.3 Global Sunitinib Generics Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Sunitinib Generics by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Sunitinib Generics Manufacturer Market Share in 2025
- 3.4.3 Top 6 Sunitinib Generics Manufacturer Market Share in 2025
- 3.5 Sunitinib Generics Market: Overall Company Footprint Analysis
- 3.5.1 Sunitinib Generics Market: Region Footprint
- 3.5.2 Sunitinib Generics Market: Company Product Type Footprint
- 3.5.3 Sunitinib Generics Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Sunitinib Generics Market Size by Region
- 4.1.1 Global Sunitinib Generics Sales Quantity by Region (2021-2032)
- 4.1.2 Global Sunitinib Generics Consumption Value by Region (2021-2032)
- 4.1.3 Global Sunitinib Generics Average Price by Region (2021-2032)
- 4.2 North America Sunitinib Generics Consumption Value (2021-2032)
- 4.3 Europe Sunitinib Generics Consumption Value (2021-2032)
- 4.4 Asia-Pacific Sunitinib Generics Consumption Value (2021-2032)
- 4.5 South America Sunitinib Generics Consumption Value (2021-2032)
- 4.6 Middle East & Africa Sunitinib Generics Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Sunitinib Generics Sales Quantity by Type (2021-2032)
- 5.2 Global Sunitinib Generics Consumption Value by Type (2021-2032)
- 5.3 Global Sunitinib Generics Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Sunitinib Generics Sales Quantity by Application (2021-2032)
- 6.2 Global Sunitinib Generics Consumption Value by Application (2021-2032)
- 6.3 Global Sunitinib Generics Average Price by Application (2021-2032)
7 North America
- 7.1 North America Sunitinib Generics Sales Quantity by Type (2021-2032)
- 7.2 North America Sunitinib Generics Sales Quantity by Application (2021-2032)
- 7.3 North America Sunitinib Generics Market Size by Country
- 7.3.1 North America Sunitinib Generics Sales Quantity by Country (2021-2032)
- 7.3.2 North America Sunitinib Generics Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Sunitinib Generics Sales Quantity by Type (2021-2032)
- 8.2 Europe Sunitinib Generics Sales Quantity by Application (2021-2032)
- 8.3 Europe Sunitinib Generics Market Size by Country
- 8.3.1 Europe Sunitinib Generics Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Sunitinib Generics Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sunitinib Generics Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Sunitinib Generics Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Sunitinib Generics Market Size by Region
- 9.3.1 Asia-Pacific Sunitinib Generics Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Sunitinib Generics Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Sunitinib Generics Sales Quantity by Type (2021-2032)
- 10.2 South America Sunitinib Generics Sales Quantity by Application (2021-2032)
- 10.3 South America Sunitinib Generics Market Size by Country
- 10.3.1 South America Sunitinib Generics Sales Quantity by Country (2021-2032)
- 10.3.2 South America Sunitinib Generics Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sunitinib Generics Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Sunitinib Generics Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Sunitinib Generics Market Size by Country
- 11.3.1 Middle East & Africa Sunitinib Generics Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Sunitinib Generics Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Sunitinib Generics Market Drivers
- 12.2 Sunitinib Generics Market Restraints
- 12.3 Sunitinib Generics Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Sunitinib Generics and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Sunitinib Generics
- 13.3 Sunitinib Generics Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Sunitinib Generics Typical Distributors
- 14.3 Sunitinib Generics Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Sunitinib Generics. Industry analysis & Market Report on Sunitinib Generics is a syndicated market report, published as Global Sunitinib Generics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Sunitinib Generics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
